Results 71 to 80 of about 1,145 (113)

Novel combinatorial approach: Harnessing HIV protease inhibitors to enhance amphotericin B's antifungal efficacy in cryptococcosis. [PDF]

PLoS One
Alkashef NM, Seleem MN.
europepmc   +1 more source

Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes. [PDF]

Mol Pharm
Murray JD, Patel RP, Bennett-Lenane H, O'Dwyer PJ, Griffin BT, Polli JE.   +5 more
europepmc   +1 more source

Elbasvir Inhibits Hepatitis E Virus Internalization and, in Combination with Ribavirin, Achieves Sustained Viral Suppression In Vitro. [PDF]

Pathogens
Primadharsini PP, Nagashima S, Takahashi M, Murata K, Okamoto H.   +4 more
europepmc   +1 more source

Large-scale evaluation of HIV-1 DNA drug resistance testing as a robust tool for clinical decision-making: A nationwide study in China. [PDF]

J Pharm Anal
Wu C, Zhang L, Chen Z, Ma W, Fu Y, Yang K, Liu M, Li Y, Chen X, Hou M, Liu M, Deng A, Zhao Q, Zhang L, Wang Q, Peng J, Li Y, Deng K, Bai J, Long H, Chen Y, Wang H, He Y, Li J, Guo J, Cao B, Cui Y, Wang M, Zhu T, Yao J, Wang T.   +30 more
europepmc   +1 more source

Virologic outcomes on dolutegravir-, atazanavir-, or efavirenz-based ART in urban Zimbabwe: A longitudinal study. [PDF]

PLoS One
Shamu T, Egger M, Mudzviti T, Chimbetete C, Manasa J, Anderegg N.   +5 more
europepmc   +1 more source

Drug-Drug Interactions in Recently Approved Antibacterials: A Mini Review. [PDF]

Eur J Drug Metab Pharmacokinet
Baccari I, Bergmann F, Zeitlinger M.
europepmc   +1 more source

Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat. [PDF]

CPT Pharmacometrics Syst Pharmacol
Frechen S, Ince I, Dallmann A, Gerisch M, Jungmann NA, Becker C, Lobmeyer M, Trujillo ME, Xu S, Burghaus R, Meyer M.   +10 more
europepmc   +1 more source

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs. [PDF]

Biomacromolecules
Starenko D, Kostka L, Behalova K, Kotrchova L, Subr V, Kovarova J, Roubalova R, Sirova M, Etrych T, Kovar M.   +9 more
europepmc   +1 more source

En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa. [PDF]

JID Innov
Wimmer B, Friedrich A, Poeltner K, Edobor G, Mosshammer C, Temaj G, Rathner A, Karl T, Krauss J, von Hagen J, Gerner C, Breitenbach M, Hintner H, Bauer JW, Breitenbach-Koller H.   +14 more
europepmc   +1 more source

Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability. [PDF]

Antimicrob Agents Chemother
Mulato A, Lansdon E, Aoyama R, Voigt J, Lee M, Liclican A, Lee G, Singer E, Stafford B, Gong R, Murray B, Chan J, Lee J, Xu Y, Ahmadyar S, Gonzalez A, Cho A, Stepan GJ, Schmitz U, Schultz B, Marchand B, Brumshtein B, Wang R, Yu H, Cihlar T, Xu L, Yant SR.   +26 more
europepmc   +1 more source